News | Proton Therapy | October 28, 2016

With the number of treated patients growing by over 20 percent year by year, patient access will double by 2020, according to the company

IBA, proton therapy, 50,000 patients treated, milestone

October 27, 2016 — IBA announced in September that 50,000 patients have been treated by clinical partners using IBA’s proton therapy technology.

Today, on average, one new patient is treated every hour on IBA systems around the globe, according to Yves Jongen, chief research officer and founder of IBA. The company’s mission, Jongen said, is to make proton therapy available to an estimated 20 percent of radiation patients that could benefit from this type of treatment.

More and more clinical opinion leaders are working on collecting and producing evidence confirming the added value of proton therapy. This addresses not only comparative clinical outcome, but also economic effectiveness of the total treatment. Proton therapy is offering new hope for patients with specific brain, eye, lung and head and neck cancers, due to their very sensitive locations in the body, where it is imperative to preserve surrounding healthy tissue. Most importantly, proton therapy has emerged as a preferred treatment option for pediatric cases, according to IBA, where the damage done to the still growing tissues and organs of children is often irreversible.

This is the reason why IBA said it is investing between 12-15 percent of its revenue in research and development (R&D) — currently the largest share in the sector. One of the outcomes of IBA’s R&D was the ProteusOne proton therapy solution. This is the most compact proton therapy system ever designed, according to the company, which is easier to implement, operate and finance.

IBA said the future of proton therapy is even more encouraging in the light of the advent of adaptive proton therapy (adaPT), widely considered as the next breakthrough in the field. Adaptive workflows, as modular proton therapy processes, add yet another layer of accuracy in what many consider the most precise and least intrusive cancer treatment method. IBA recently created an international online Community platform, leadingthepath.org, to enable experts in the field from all over the world to exchange experiences, discuss best practices and enhance knowledge, to improve the next generation of proton therapy treatment.

For more information: www.iba-worldwide.com


Related Content

News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 09, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
News | Artificial Intelligence

May 22, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, recently ...

Time May 22, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 21, 2024 — RaySearch Laboratories AB announced that the oncology information system RayCare* 2024A has been ...

Time May 21, 2024
arrow
Subscribe Now